M. Eileen Dolan
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Papers in
-
- DNA Repair Mechanisms 3
- Cancer therapeutics and mechanisms 2
- Coenzyme Q10 studies and effects 1
- Oncology 2
- Lung Cancer Research Studies 1
- Co-authors
- Robert C. Moschel (4 shared papers)Anthony E. Pegg (5 shared papers)G. Michael Felker (2 shared papers)Deanna L. Kroetz (1 shared paper)Peixian Chen (1 shared paper)Federico Innocenti (1 shared paper)Erin G. Schuetz (1 shared paper)Soma Das (1 shared paper)
- Journals
- Cancer Chemotherapy and Pharmacology (4 papers)Journal of Clinical Oncology (1 paper)Molecular Cancer Therapeutics (1 paper)Environmental Health Perspectives (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United States
In The Last Decade
M. Eileen Dolan
8 papers receiving 520 citations
Peers
Comparison fields: 5 of 56
- Genetics 101
- Oncology 200
- Cancer Research 81
- Pharmacology 40
- Molecular Biology 300
Countries citing papers authored by M. Eileen Dolan
This map shows the geographic impact of M. Eileen Dolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Eileen Dolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Eileen Dolan more than expected).
Fields of papers citing papers by M. Eileen Dolan
This network shows the impact of papers produced by M. Eileen Dolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Eileen Dolan. The network helps show where M. Eileen Dolan may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Eileen Dolan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 210 | |
| 2 | 1992 | 92 | |
| 3 | 2007 | 71 | |
| 4 | 1993 | 68 | |
| 5 | 1989 | 31 | |
| 6 | 1997 | 23 | |
| 7 | 1985 | 18 | |
| 8 | 2000 | 17 |
About M. Eileen Dolan
M. Eileen Dolan is a scholar working on Molecular Biology, Oncology, Cancer Research, Genetics and Rheumatology, having authored 8 papers that have together received 530 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Cancer therapeutics and mechanisms (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Folate and B Vitamins Research (1 paper), Coenzyme Q10 studies and effects (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Lung Cancer Research Studies (1 paper) and Amino Acid Enzymes and Metabolism (1 paper). The work is most often cited by research in Genetics (101 citations), Oncology (200 citations), Cancer Research (81 citations), Pharmacology (40 citations) and Molecular Biology (300 citations). M. Eileen Dolan has collaborated with scholars based in United States. Frequent co-authors include Robert C. Moschel, Anthony E. Pegg, G. Michael Felker, Deanna L. Kroetz, Peixian Chen, Federico Innocenti, Erin G. Schuetz, Soma Das, Gary L. Rosner and Jacqueline Ramı́rez. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Environmental Health Perspectives and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.